quipazine has been researched along with alpha-aminopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, A; Bucciarelli, S; Gotfredsen, CH; Høj, LJ; Langkilde, AE; Meier, S; Narayanan, D; Sattler, M; Softley, C; Solbak, SMØ; Zang, J | 1 |
| Evans, DC; Hemrick-Luecke, SK | 1 |
2 other study(ies) available for quipazine and alpha-aminopyridine
| Article | Year |
|---|---|
Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery.
Topics: Azoles; Drug Discovery; Humans; Indoles; Isoindoles; Molecular Structure; NADPH Oxidase 2; NADPH Oxidases; Organoselenium Compounds; Protein Binding; Structure-Activity Relationship | 2020 |
Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Topics: Aminopyridines; Amphetamines; Animals; Corticosterone; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Hypothalamo-Hypophyseal System; Indoles; Male; Piperazines; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2002 |